Induction of ERBB2 nuclear transport after radiation in breast cancer cells

Abstract

The ERBB2 nuclear transport in breast cancer cell lines after radiation and its possible role in radiation tolerance were observed. Confocal microscopy and Western blotting were applied to detect the nuclear ERBB2 expression after radiation in breast carcinomas cells. And the effects of Herceptin, AG825 and Cisplatin on the expression of nuclear ERBB2 were investigated. Survival fractions were also observed. After radiation, compared with control group, confocal microscopy and Western blot revealed that the expression of nuclear ERBB2 was increased in breast cancer cells time-dependently. Herceptin, and AG825 could significantly inhibit the radiation-induced nuclear ERBB2 expression, and decrease survival fractions. Cisplatin also induced the nuclear ERBB2 expression in breast cancer cells with high ERBB2 expression. It was concluded that radiation could induce ERBB2 nuclear transport, and nuclear ERBB2 may correlate with radiation resistance in breast cancer cells with high ERBB2 expression.

Keywords

c-ERBB-2 / breast cancer / radiosensitivity

References

[1] WardmanP.. Chemical radiosensitizers for use in radiotherapy. Clin Oncol, 2007, 19(6): 397-417

[2] ChungT.D., BroaddusW.C.. Molecular targeting in radiotherapy: Epidermal growth factor receptor. Mol Interv, 2005, 5(1): 15-19

[3] LoH.W., HsuS.C., HungM.C.. EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization. Breast Cancer Res Treat, 2006, 95(3): 211-218

[4] IrenaS.. Epidermal growth factor receptor and DNA double strand break repair: The cell’s self-defense. Cell Signall, 2006, 18(10): 1537-1548

[5] MassR.D.. The HER receptor family: a rich target for therapeutic development. Int J Radiation Oncology Biol Phys, 2004, 58(3): 932-940

[6] KamioT., ShigematsuK., SouH., et al. . Immunohistochemical expression of epidermal growth factor receptors in human adrenocortical carcinoma. Hum Pathol, 1990, 21: 277-282

[7] MartiU., BurwenS.J., WellsA., et al. . Localization of epidermal growth factor receptor in hepatocyte nuclei. Hepatology, 1991, 13: 15-20

[8] LoH.W., XiaW., WeiY., et al. . Novel prognostic value of nuclear EGF receptor in breast cancer. Cancer Res, 2005, 65: 338-348

[9] RaabeT.D., DeadwylerG., VargaJ.W., et al. . Localization of neuregulin isoforms and erbB receptors in myelinating glial cells. Glia, 2004, 45: 197-207

[10] CarpenterG.. Nuclear localization and possible functions of receptor tyrosine kinases. Curr Opin Cell Biol, 2003, 15(2): 143-148

[11] Xia W, Wei Y, Du Y, et al. Nuclear expression of epidermal growth factor receptor is a novel prognostic value in patients with ovarian cancer. Mol Carcinog, 2008, [Epub ahead of print]

[12] OffterdingerM., SchoferC., WeipoltshammerK., et al. . C-erbB-3: a nuclear protein in mammary epithelial cells. J Cell Biol, 2002, 157: 929-939

[13] WangS.C., LienH.C., XiaW., et al. . Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. Cancer Cell, 2004, 6(3): 251-261

[14] DittmannK., MayerC., FehrenbacherB., et al. . Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase. J Biol Chem, 2005, 280(35): 31 182-31 189

[15] BandyopadhyayD., MandalM., AdamL., et al. . Physical interaction between epidermal growth factor receptor and DNA-dependent protein kinase in mammalian cells. J Biol Chem, 1998, 273(3): 1568-1573

[16] LeeC.M., ShrieveD.C., ZempolichK.A., et al. . Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix. Gynecol Oncol, 2005, 99(2): 415-421

[17] LiangK., LuY., JinW., et al. . Sensitization of breast cancer cells to radiation by trastuzumab. Mol Cancer Ther, 2003, 2(11): 1113-1120

[18] PancholiS., LykkesfeldtA.E., HilmiC., et al. . ERBB2 influences the subcellular localization of the estrogen receptor in tamoxifen-resistant MCF-7 cells leading to the activation of AKT and RPS6KA2. Endocr Relat Cancer, 2008, 15(4): 985-1002

[19] CaoN., LiS., WangZ., et al. . NF-kappaB-mediated HER2 overexpression in radiation-adaptive resistance. Radiat Res, 2009, 171(1): 9-21

[20] SasakiM.S.. Advances in the biophysical and molecular bases of radiation cytogenetics. Int J Radiat Biol, 2009, 85(1): 26-47

[21] CollisS.J., DeWeeseT.L., JeggoP.A., et al. . The life and death of DNA-PK. Oncogene, 2005, 24(6): 949-961